Clinical Trial Update: Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated sirolimus for chronic allograft nephropathy in pediatric kidney transplant recipients; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: University of Manitoba | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED